ATE420210T1 - Diagnose des brustkrebsrisikos - Google Patents

Diagnose des brustkrebsrisikos

Info

Publication number
ATE420210T1
ATE420210T1 AT04768320T AT04768320T ATE420210T1 AT E420210 T1 ATE420210 T1 AT E420210T1 AT 04768320 T AT04768320 T AT 04768320T AT 04768320 T AT04768320 T AT 04768320T AT E420210 T1 ATE420210 T1 AT E420210T1
Authority
AT
Austria
Prior art keywords
breast cancer
diagnosis
cancer risk
risk
cancer
Prior art date
Application number
AT04768320T
Other languages
English (en)
Inventor
Martin Andrew Crockard
Janice Roberta Bailie
John Victor Lamont
Stephen Peter Fitzgerald
Original Assignee
Randox Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Lab Ltd filed Critical Randox Lab Ltd
Application granted granted Critical
Publication of ATE420210T1 publication Critical patent/ATE420210T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04768320T 2003-09-03 2004-09-02 Diagnose des brustkrebsrisikos ATE420210T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0320648.9A GB0320648D0 (en) 2003-09-03 2003-09-03 Molecular marker

Publications (1)

Publication Number Publication Date
ATE420210T1 true ATE420210T1 (de) 2009-01-15

Family

ID=28686847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04768320T ATE420210T1 (de) 2003-09-03 2004-09-02 Diagnose des brustkrebsrisikos

Country Status (9)

Country Link
US (1) US20090311671A1 (de)
EP (1) EP1660676B1 (de)
JP (1) JP2007503826A (de)
CN (1) CN1846001A (de)
AT (1) ATE420210T1 (de)
DE (1) DE602004018940D1 (de)
ES (1) ES2319533T3 (de)
GB (1) GB0320648D0 (de)
WO (1) WO2005024060A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606954D0 (en) * 2006-04-06 2006-05-17 Randox Lab Ltd Method
KR102071491B1 (ko) * 2017-11-10 2020-01-30 주식회사 디시젠 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030044859A1 (en) * 1996-08-19 2003-03-06 Henslee Jerry G. Reagents and methods useful for detecting diseases of the breast
US6012053A (en) * 1997-06-23 2000-01-04 Lycos, Inc. Computer system with user-controlled relevance ranking of search results
JP3422776B2 (ja) * 1998-08-04 2003-06-30 ダイアデクスアス・インコーポレーテッド 乳癌を診断、監視、病期決定、造影及び治療する新規な方法
US7065494B1 (en) * 1999-06-25 2006-06-20 Nicholas D. Evans Electronic customer service and rating system and method
US6936424B1 (en) * 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
JP2003526342A (ja) * 1999-11-23 2003-09-09 ディアデクサス インコーポレーテッド 乳癌の診断、モニタニング、ステージング、イメージングおよび処置の新規方法
CA2411404A1 (en) * 2000-05-26 2001-12-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
GB0026353D0 (en) * 2000-10-27 2000-12-13 Canon Kk Apparatus and a method for facilitating searching
JP2005512510A (ja) * 2001-05-16 2005-05-12 ノバルティス アクチエンゲゼルシャフト 予後および治療標的として乳癌で発現される遺伝子
DE60239535D1 (de) * 2001-06-18 2011-05-05 Rosetta Inpharmatics Llc Diagnose und prognose von brustkrebspatientinnen
EP1460898A4 (de) * 2002-01-03 2006-05-24 Univ Texas Wt1-antisense-oligos für die hemmung von brustkrebs

Also Published As

Publication number Publication date
ES2319533T3 (es) 2009-05-08
CN1846001A (zh) 2006-10-11
GB0320648D0 (en) 2003-10-01
DE602004018940D1 (de) 2009-02-26
EP1660676B1 (de) 2009-01-07
JP2007503826A (ja) 2007-03-01
EP1660676A1 (de) 2006-05-31
US20090311671A1 (en) 2009-12-17
WO2005024060A1 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
AU2003263834A8 (en) Mutations in nod2 are associated with fibrostenosing disease in patients with crohn's disease
UA86582C2 (ru) Способ лечения хореи гентингтона ейкозапентеновой кислотой
DE69922261D1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
AU2002327308A1 (en) Methods for evaluating pathologic conditions using extracellular rna
Ali et al. Molecular characterization of echinococcus species in Khyber pakhtunkhwa, pakistan
DE60028544D1 (de) Prostata-spezifische gene zur diagnose, prognose und behandlung von prostata-krebs
EP1565582A4 (de) Verfahren zur identifizierung des brustkrebsrisikos und behandlungen davon
WO2004078035A3 (en) Expression profiles for breast cancer and methods of use
ATE461294T1 (de) Brustkrebsdiagnoseverfahren
CN101045944B (zh) 检测六种腹泻致病菌的基因芯片、制备方法及试剂盒
EP1556493A4 (de) Neue vollständige genomische dna des japanenzephalitis-virus, infektiöse jev cdna daraus und deren verwendung
NO20070780L (no) Celloverflateprotein.
DE602004018940D1 (de) Diagnose des brustkrebsrisikos
DK1037916T3 (da) Erythrovirus og dets anvendelser
ATE545708T1 (de) Krebsantigen mage-a9 und verwendungen davon
ATE431556T1 (de) Bestimmung von kurzkettiger srl- alkoholdehydrogenase (dhrs4) als biomarker für entzündungen und infektionen
ATE498020T1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
BRPI0413364A (pt) proteases especìficas de ubiquitina
FI990380A7 (fi) Diagnostinen ja seulontamenetelmä
DE60029939D1 (de) Diagnosisverfahren für whipples krankheit
WO2003040388A3 (de) Verfahren zum nachweis parodontitis und karies assoziierter bakterien
GB0227274D0 (en) Probes
DE50214523D1 (de) Nukleotidträger zur diagnose und therapie oraler erkrankungen
MX2024005607A (es) Sustrato enzimatico fret y sus usos en el cancer de pulmon.
DE60035857D1 (de) Nukleinsäure- und aminosäuresequenzen von durch hämoglobin induzierbaren genen aus candida albicans und die verwendung dieser sequenzen in reagenzien zur diagnose von disseminierten candida albicans infektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties